Cyclic Nucleotide Phosphodiesterases, Type 5
- Name
- Cyclic Nucleotide Phosphodiesterases, Type 5
- Accession Number
- DBCAT001777
- Description
Not Available
- Drugs
Drug Drug Description Gisadenafil Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia. - Drugs & Drug Targets
Drug Target Type